当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
Aralast; Aralast NP, Alpha-1-Proteinase Inhibitor (Human)
药品名称
Aralast; Aralast NP, Alpha-1-Proteinase Inhibitor (Human)
承诺描述
Conduct and report the results of a pilot trial to determine the effect of regular administration of the product on one or more clinically meaningful endpoint(s). Examples of acceptable endpoints include pulmonary exacerbations, serial pulmonary functions, and serial quantitative computerized axial tomographic (CT) lung scans.
承诺状态描述
The final protocol due date has passed with no final protocol received.